Skip to main content
logo
TWi Biotechnology, Inc. (TPEX:6610)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.00
+0.85 (4.22%)
Mar 4, 2026, 1:51 PM CST

TWi Biotechnology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
----66.41.25
Revenue Growth (YoY)
----5228.81%-87.11%
Cost of Revenue
----0.911.04
Gross Profit
----65.480.2
Selling, General & Admin
29.3228.3521.1515.6214.1213.77
Research & Development
125.06150.14148.4174.5666.6684.99
Operating Expenses
154.37178.49169.5690.1880.7998.76
Operating Income
-154.37-178.49-169.56-90.18-15.3-98.56
Interest Expense
-0.13-0.16-0.09-0.05-0.09-0.02
Interest & Investment Income
5.016.632.831.671.413.47
Currency Exchange Gain (Loss)
-7.437.21-4.2712.37-1.78-6.33
Other Non Operating Income (Expenses)
1.6500.3900.460.96
EBT Excluding Unusual Items
-155.28-164.81-170.69-76.18-15.3-100.48
Other Unusual Items
--0.01---0.03
Pretax Income
-155.28-164.81-170.68-76.18-15.3-100.51
Income Tax Expense
-----1.35
Net Income
-155.28-164.81-170.68-76.18-15.3-101.86
Net Income to Common
-155.28-164.81-170.68-76.18-15.3-101.86
Shares Outstanding (Basic)
888873676767
Shares Outstanding (Diluted)
888873676767
Shares Change (YoY)
5.63%19.75%8.52%---
EPS (Basic)
-1.77-1.88-2.33-1.13-0.23-1.51
EPS (Diluted)
-1.77-1.88-2.33-1.13-0.23-1.51
Free Cash Flow
-131.07-155.72-134.22-60.24-34.69-62.58
Free Cash Flow Per Share
-1.49-1.78-1.83-0.89-0.51-0.93
Gross Margin
----98.63%16.29%
Operating Margin
-----23.04%-7909.95%
Profit Margin
-----23.04%-8174.80%
Free Cash Flow Margin
-----52.24%-5022.39%
EBITDA
-147.28-171.36-162.33-82.34-6.72-89.56
EBITDA Margin
-----10.12%-
D&A For EBITDA
7.17.137.237.838.589
EBIT
-154.37-178.49-169.56-90.18-15.3-98.56
EBIT Margin
-----23.04%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.